Literature DB >> 19752236

A novel role for plasmin-mediated degradation of opsonizing antibody in the evasion of host immunity by virulent, but not attenuated, Francisella tularensis.

Deborah D Crane1, Shayna L Warner, Catharine M Bosio.   

Abstract

Opsonization by Abs represents a critical component of the host immune response against many pathogens. The mechanisms by which virulent microbes evade this protective response are not completely understood. In disease mediated by Francisella tularensis, Ab can effectively protect against infections with attenuated strains, for example, LVS, but not virulent strains such as SchuS4. Thus, it is likely that SchuS4 has mechanisms, which are not present in LVS, that allow evasion of opsonization by Ab, dampening the protective effects of these host molecules. Here we demonstrate that evasion of Ab-mediated opsonization and phagocytosis by the highly virulent SchuS4 is associated with its ability to bind the host serine protease plasmin. SchuS4, but not the closely related LVS, bound active plasmin. Plasmin bound SchuS4 degraded exogenous and opsonizing Abs, whereas LVS failed to do so. Furthermore, plasmin-mediated inhibition of Ab opsonization by SchuS4 also inhibited Ab-mediated uptake of this bacterium by macrophages. Ab-mediated uptake of uncoated and opsonized SchuS4 elicited a strong proinflammatory response in infected macrophages. However, plasmin-coated, opsonized SchuS4 poorly elicited production of these protective proinflammatory cytokines. This unique host-pathogen interplay is a novel immune evasion strategy utilized by virulent F. tularensis, and it provides one explanation for the ability of Ab to protect against attenuated, but not virulent, strains of F. tularensis. This mechanism may also represent a more common hereto unrecognized strategy by which virulent bacteria evade detection and clearance by Ig.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19752236      PMCID: PMC2748154          DOI: 10.4049/jimmunol.0901655

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  36 in total

1.  Yersinia pestis Pla has multiple virulence-associated functions.

Authors:  Kaarina Lähteenmäki; Maini Kukkonen; Silja Jaatinen; Marjo Suomalainen; Hanna Soranummi; Ritva Virkola; Hannu Lång; Timo K Korhonen
Journal:  Adv Exp Med Biol       Date:  2003       Impact factor: 2.622

2.  Plasmin(ogen)-binding alpha-enolase from Streptococcus pneumoniae: crystal structure and evaluation of plasmin(ogen)-binding sites.

Authors:  Stefanie Ehinger; Wolf-Dieter Schubert; Simone Bergmann; Sven Hammerschmidt; Dirk W Heinz
Journal:  J Mol Biol       Date:  2004-10-29       Impact factor: 5.469

3.  Candida albicans binds human plasminogen: identification of eight plasminogen-binding proteins.

Authors:  Jonathan D Crowe; Isla K Sievwright; Gillian C Auld; Norma R Moore; Neil A R Gow; Nuala A Booth
Journal:  Mol Microbiol       Date:  2003-03       Impact factor: 3.501

Review 4.  Bacterial plasminogen activators and receptors.

Authors:  K Lähteenmäki; P Kuusela; T K Korhonen
Journal:  FEMS Microbiol Rev       Date:  2001-12       Impact factor: 16.408

5.  The generation of enzymatically active plasmin on the surface of spirochetes.

Authors:  J L Coleman; J L Benach
Journal:  Methods       Date:  2000-06       Impact factor: 3.608

6.  Fc receptor regulation of protective immunity against Chlamydia trachomatis.

Authors:  Terri Moore; Godwin A Ananaba; Jacqueline Bolier; Samera Bowers; Tesfaye Belay; Francis O Eko; Joseph U Igietseme
Journal:  Immunology       Date:  2002-02       Impact factor: 7.397

7.  Francisella tularensis infection-derived monoclonal antibodies provide detection, protection, and therapy.

Authors:  Anne G Savitt; Patricio Mena-Taboada; Gloria Monsalve; Jorge L Benach
Journal:  Clin Vaccine Immunol       Date:  2009-01-28

8.  Lack of O-antigen is essential for plasminogen activation by Yersinia pestis and Salmonella enterica.

Authors:  Maini Kukkonen; Marjo Suomalainen; Päivi Kyllönen; Kaarina Lähteenmäki; Hannu Lång; Ritva Virkola; Ilkka M Helander; Otto Holst; Timo K Korhonen
Journal:  Mol Microbiol       Date:  2004-01       Impact factor: 3.501

9.  Francisella tularensis inhibits Toll-like receptor-mediated activation of intracellular signalling and secretion of TNF-alpha and IL-1 from murine macrophages.

Authors:  Max Telepnev; Igor Golovliov; Thomas Grundström; Arne Tärnvik; Anders Sjöstedt
Journal:  Cell Microbiol       Date:  2003-01       Impact factor: 3.715

10.  Antibody-mediated immunity to the obligate intracellular bacterial pathogen Coxiella burnetii is Fc receptor- and complement-independent.

Authors:  Jeffrey G Shannon; Diane C Cockrell; Kazue Takahashi; Gregory L Stahl; Robert A Heinzen
Journal:  BMC Immunol       Date:  2009-05-08       Impact factor: 3.615

View more
  26 in total

1.  Multiple mechanisms of NADPH oxidase inhibition by type A and type B Francisella tularensis.

Authors:  Ramona L McCaffrey; Justin T Schwartz; Stephen R Lindemann; Jessica G Moreland; Blake W Buchan; Bradley D Jones; Lee-Ann H Allen
Journal:  J Leukoc Biol       Date:  2010-07-07       Impact factor: 4.962

2.  TLR4-dependent activation of inflammatory cytokine response in macrophages by Francisella elongation factor Tu.

Authors:  Jyotika Sharma; Bibhuti B Mishra; Qun Li; Judy M Teale
Journal:  Cell Immunol       Date:  2011-03-29       Impact factor: 4.868

3.  Outer membrane vesicles displaying engineered glycotopes elicit protective antibodies.

Authors:  Linxiao Chen; Jenny L Valentine; Chung-Jr Huang; Christine E Endicott; Tyler D Moeller; Jed A Rasmussen; Joshua R Fletcher; Joseph M Boll; Joseph A Rosenthal; Justyna Dobruchowska; Zhirui Wang; Christian Heiss; Parastoo Azadi; David Putnam; M Stephen Trent; Bradley D Jones; Matthew P DeLisa
Journal:  Proc Natl Acad Sci U S A       Date:  2016-06-06       Impact factor: 11.205

4.  Role of TLR signaling in Francisella tularensis-LPS-induced, antibody-mediated protection against Francisella tularensis challenge.

Authors:  Leah E Cole; Barbara J Mann; Kari Ann Shirey; Katharina Richard; Yang Yang; Patricia J Gearhart; Kirsty L Chesko; Rose M Viscardi; Stefanie N Vogel
Journal:  J Leukoc Biol       Date:  2011-07-12       Impact factor: 4.962

5.  Hematopoietic MyD88 and IL-18 are essential for IFN-γ-dependent restriction of type A Francisella tularensis infection.

Authors:  Jerod A Skyberg; Carolyn A Lacey
Journal:  J Leukoc Biol       Date:  2017-09-26       Impact factor: 4.962

6.  Novel catanionic surfactant vesicle vaccines protect against Francisella tularensis LVS and confer significant partial protection against F. tularensis Schu S4 strain.

Authors:  Katharina Richard; Barbara J Mann; Lenea Stocker; Eileen M Barry; Aiping Qin; Leah E Cole; Matthew T Hurley; Robert K Ernst; Suzanne M Michalek; Daniel C Stein; Philip Deshong; Stefanie N Vogel
Journal:  Clin Vaccine Immunol       Date:  2013-12-18

Review 7.  Antibodies for biodefense.

Authors:  Jeffrey W Froude; Bradley Stiles; Thibaut Pelat; Philippe Thullier
Journal:  MAbs       Date:  2011-11-01       Impact factor: 5.857

8.  Binding and activation of host plasminogen on the surface of Francisella tularensis.

Authors:  Shawn R Clinton; James E Bina; Thomas P Hatch; Michael A Whitt; Mark A Miller
Journal:  BMC Microbiol       Date:  2010-03-12       Impact factor: 3.605

9.  B1a cells enhance susceptibility to infection with virulent Francisella tularensis via modulation of NK/NKT cell responses.

Authors:  Deborah D Crane; Amanda J Griffin; Tara D Wehrly; Catharine M Bosio
Journal:  J Immunol       Date:  2013-02-01       Impact factor: 5.422

10.  Interleukin-17 protects against the Francisella tularensis live vaccine strain but not against a virulent F. tularensis type A strain.

Authors:  Jerod A Skyberg; Maryclare F Rollins; Joshua W Samuel; Marjorie D Sutherland; John T Belisle; David W Pascual
Journal:  Infect Immun       Date:  2013-06-17       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.